Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
PLX > SEC Filings for PLX > Form 8-K on 11-Sep-2013All Recent SEC Filings

Show all filings for PROTALIX BIOTHERAPEUTICS, INC.

Form 8-K for PROTALIX BIOTHERAPEUTICS, INC.


11-Sep-2013

Regulation FD Disclosure, Financial Statements and Exhibits


Item 7.01. Regulation FD Disclosure

On September 11, 2013, Protalix BioTherapeutics, Inc. (the "Company") issued a press release announcing that it intends, subject to market conditions, to offer and sell $60 million principal amount of its convertible senior notes due 2018 (the "Notes") through a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The Company expects to grant the initial purchaser an option to purchase up to an additional $9 million principal amount of Notes, exercisable for 30 days after the pricing date of the notes offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. A copy of the press release is furnished as Exhibit 99.1.

A copy of the Company's Management Presentation is furnished as Exhibit 99.2 to this Item 7.01.

The information contained in Item 7.01 of this report and in Exhibits 99.1 and 99.2 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.



Item 9.01. Financial Statements and Exhibits

(d) Exhibits

99.1 Press release dated September 11, 2013.

99.2 Investor Presentation.

  Add PLX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for PLX - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.